Search Results 461-470 of 10965 for Viscosity

  1. Mayo Clinic

    Share · Tweet . IMG-20076771. Home; MY01424Vsitswithbalancetrainer. Fuel groundbreaking medical research! Give Today. Your donation powers the future of ...

  2. Varicose veins - Doctors and departments - Mayo Clinic

    This common condition causes lines or cords to develop under the skin. Learn self-care steps to take and what treatments there are.

  3. A Study to Evaluate Molecular and Biochemical Testing for Suspected Hereditary Disorders - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Mayo Clinic

    Share · Tweet . IMG-20385361. Home; 3663436_0033_3col. Fuel groundbreaking medical research! Give Today. Your donation powers the future of medicine and ...

  5. Mayo Clinic

    MY01424Supportedvsits · Don't miss your chance! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers · International Patients · Charitable ...

  6. Varicose veins - Doctors and departments - Mayo Clinic

    This common condition causes lines or cords to develop under the skin. Learn self-care steps to take and what treatments there are.

  7. Varicose veins - Doctors and departments - Mayo Clinic

    This common condition causes lines or cords to develop under the skin. Learn self-care steps to take and what treatments there are.

  8. Varicose veins - Doctors and departments - Mayo Clinic

    This common condition causes lines or cords to develop under the skin. Learn self-care steps to take and what treatments there are.

  9. Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations - Mayo Clinic

    About this study. To determine the antitumor activity of tipifarnib in patients with locally advanced unresectable or metastatic, relapsed and/or refractory ...

  10. Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination with Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer - Mayo Clinic

    Dabrafenib is a potent and selective inhibitor of BRAF kinase activity. This is a Phase II, non-randomized, open-label study to assess the efficacy, safety, and ...